Co-expression of mutated Jak2 and Calr enhances myeloproliferative phenotype in mice without loss of stem cell fitness

Am J Hematol. 2022 Nov;97(11):E396-E399. doi: 10.1002/ajh.26688. Epub 2022 Aug 30.

Authors

Christina M Schueller^{1

2}, Andrea Majoros², Harini Nivarthi², Robert Kralovics¹

Affiliations

¹ Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
² CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

PMID: 36053947
DOI: 10.1002/ajh.26688

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Calreticulin / genetics
Janus Kinase 2* / genetics
Mice
Mutation
Myeloproliferative Disorders* / genetics
Phenotype
Stem Cells

Substances

Calreticulin
Janus Kinase 2